13 September 2022 - The first and only body identical HRT for post-menopausal oestrogen deficiency, Bijuve, has been passed by ...
12 September 2022 - The SMC decision follows the recent positive NICE recommendation for Idefirix in England, Wales and Northern ...
18 August 2022 - The SMC approval brings much needed boost to asthma sufferers across Scotland. ...
10 August 2022 - Newly diagnosed patients will become the first to access systemic light chain amyloidosis treatment in the ...
8 August 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
11 July 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
13 June 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
10 May 2022 - NICE recommendation for Forxiga could entitle 53,000 adults to the new kidney disease therapy ...
9 May 2022 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
12 April 2022 - Advice on three new medicines for use in conditions including a rare and fatal genetic condition affecting ...
8 March 2022 - A new UK wide health technology assessment access forum has been developed by partners including the ...
7 March 2022 - Sotorasib Is indicated as monotherapy for the treatment of adult patients with KRAS G12C mutated locally advanced ...
9 March 2022 - Trodelvy is accepted for use in metastatic triple negative breast cancer. patients who have already received two ...
7 March 2022 - Diurnal provides an update on the status of reimbursement of Efmody (modified release hydrocortisone) for NHS ...
7 March 2022 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...